Benign neoplasm of transverse colon
ICD-10 D12.3 is a billable code used to indicate a diagnosis of benign neoplasm of transverse colon.
A benign neoplasm of the transverse colon refers to a non-cancerous tumor that arises from the tissues of the transverse colon, which is the part of the large intestine that crosses the abdomen from right to left. These neoplasms can include adenomas, hyperplastic polyps, and other benign growths. While benign, these neoplasms can still pose clinical significance, as they may lead to symptoms such as abdominal pain, obstruction, or changes in bowel habits. Surveillance is often recommended to monitor for any changes in size or characteristics that could indicate a risk of malignant transformation. The management of benign neoplasms typically involves regular colonoscopic surveillance, especially if the neoplasm is large or has dysplastic features. The risk of malignant potential varies depending on the type of neoplasm, with adenomatous polyps having a higher risk of progression to colorectal cancer compared to hyperplastic polyps. Therefore, appropriate coding and documentation are essential for ensuring proper management and follow-up care.
Detailed descriptions of the neoplasm type, size, and any dysplastic features observed during colonoscopy.
Patients presenting with abdominal pain, rectal bleeding, or incidental findings during routine colonoscopy.
Ensure that surveillance intervals are documented, especially if the neoplasm has characteristics that warrant closer monitoring.
Histopathological reports detailing the type of neoplasm and any relevant findings.
Pathological evaluation of biopsy specimens from colonoscopic procedures.
Accurate reporting of findings is crucial for determining the appropriate coding and follow-up care.
Used for surveillance of benign neoplasms in the transverse colon.
Document findings, size, and type of neoplasm.
Gastroenterologists should ensure that surveillance intervals are clearly noted.
Accurate coding of benign neoplasms is crucial for appropriate management and surveillance, as it helps healthcare providers monitor potential risks and ensures proper reimbursement for services rendered.
